Industry Background:
Hantavirus is also known as Orthohantavirus, the virus spread mainly by rodents which can lead to hantavirus pulmonary syndrome (HPS) and other respiratory diseases. This causes potentially fatal infections with primary symptoms such as fever, muscle ache, fatigue and later it turns to shortness of breath, cough. The infections occur by breathing air that's contaminated with rodent urine and droppings leading to this infection. There are limited cure and vaccines for the treatment of hantavirus and there has been continuous research regarding the same. Infections with any type of hantavirus can produce severe disease in people, this virus in the Americas is known as "New World" hantaviruses and might cause hantavirus pulmonary syndrome. Other hantaviruses known as "old world" hantavirus are mostly found in Europe and Asia and they might cause hemorrhagic fever with renal syndrome (HFRS).This growth is primarily driven by Growing Contact of Human with Rodents Infestation, Saliva, Urine, Feces or with Dust and Rural Areas with Large Forests and Fields Increases the Rodents Population.
Globally, a noticeable market trend is evident Continuous Research and Development Carrying out in the Laboratories for Effective Treatment and Vaccines. Major Players, such as The Native Antigen Company (United Kingdom), Charles River Laboratories, Inc. (United States), Pfizer Inc. (United States), Thermo Fisher Scientific (United States), Johnson & Johnson (United States), Sanofi S.A. (France), PharmaJet, Inc. (United States) and Cigna (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
On 13th March 2018, PharmaJet the maker of innovative needle-free injection technology announced the reporting of positive interim results from the Phase 1 clinical trial conducted by the US Army Medical Research Institute of Infectious Diseases. This clinical trial is evaluating two hantavirus vaccines to prevent hemorrhagic fever with renal syndrome (HFRS) using the PharmJet Stratis needle-free injection system. Hantaan virus (HTNV) causes the most severe form of HFRS, which has a 5 to 15 percent fatality rate and affects tens of thousands of people annually.
Regulatory Insights:
According to the CDC, in North America, the incubation period (time from initial exposure to the virus and development of the first symptoms) is between one to five weeks after initial exposure to infected rodent urine, droppings, or saliva. In South American outbreaks, researchers estimate that the incubation period varies from about 12-27 days.
Market Drivers
- Growing Contact of Human with Rodents Infestation, Saliva, Urine, Feces or with Dust
- Rural Areas with Large Forests and Fields Increases the Rodents Population
Market Trend
- Continuous Research and Development Carrying out in the Laboratories for Effective Treatment and Vaccines
Restraints
- High Risk to People who Are Engaged in the Cleaning Activities Outside with High Exposure to Rodents with Hantavirus Infection
Opportunities
Awareness About Hantavirus Infection and Increasing Healthcare Funding for Proper Research
Challenges
There is Very Limited Treatment, Cure, or Vaccines for the Treatment of Hantavirus Infection
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Hantavirus Study Sheds Light on
The Hantavirus Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Hantavirus industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Hantavirus industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.